SARS-COV-2 infection and lung tumor microenvironment

Area of Science:

• Oncology
• Virology
• Immunology

Background:

• Coronavirus Disease 2019 (COVID-19) is a global pandemic with higher mortality in vulnerable populations.
• Lung cancer is a significant comorbidity associated with severe COVID-19 outcomes.
• The lung tumor microenvironment (TME) plays a crucial role in disease progression and immune response.

Purpose of the Study:

• To review the impact of the lung TME on SARS-CoV-2 infection severity.
• To explore how SARS-CoV-2 proteins modulate the lung TME.
• To discuss the implications of lung cancer treatments during the COVID-19 pandemic.

Main Methods:

• Literature review focusing on the interaction between the lung TME and SARS-CoV-2.
• Analysis of viral protein effects on immune mechanisms and cellular metabolism within the TME.
• Examination of existing research on lung cancer medications in the context of COVID-19.

Main Results:

• A compromised lung TME increases susceptibility to SARS-CoV-2 infection.
• SARS-CoV-2 proteins can disrupt immune responses, leading to cytokine storms and metabolic changes in the lung TME.
• Lung cancer treatments may influence COVID-19 outcomes.

Conclusions:

• The lung TME significantly influences COVID-19 severity in lung cancer patients.
• COVID-19 survivors, especially those with genetic susceptibility or risk factors, require monitoring for potential tumor development.
• Understanding these interactions is critical for managing co-infected patients.